Interesting facts
Interesting Facts about 16,17-Dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaene
This compound is part of an intriguing class of organic compounds known for their complex structures and unique properties. Here are some fascinating aspects:
- Structure: The compound features a characteristic pentacyclic framework, which contributes significantly to its chemical behavior and potential reactivity. The intricate arrangement of rings is a hallmark of many natural products.
- Dimethoxy Groups: The presence of two methoxy groups in the molecular structure can influence both the polarity and biological activity of the compound. This modification often enhances solubility and binding properties in various interactions.
- Applications: Compounds with such complex structures are often explored in pharmaceutical chemistry. They can serve as lead compounds in drug design due to their unique mechanisms of action.
- Research Potential: Given its unique framework, this compound may present new avenues in the development of materials with tailored electronic properties, especially in organic electronics and photovoltaics.
- Chemical Synthesis: The synthesis of such multi-cyclic compounds typically involves sophisticated synthetic strategies and can provide a thrilling challenge for chemists.
As science continues to evolve, the study of such compounds may unveil novel pathways in medicinal and materials chemistry. The complexities of their structures often lead to *unexpected discoveries*, illustrating the beauty and unpredictability of chemical research.
Synonyms
Canadine
522-97-4
Xanthopuccine
Canadin
dl-Tetrahydroberberine
DTXSID5022724
V2SSH085X8
CHEBI:22998
9,10-Dimethoxy-2,3-(methylenedioxy)berbine
NSC-36351
NSC-94918
DTXCID802724
16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaene
5,8,13,13a-tetrahydro-9,10-dimethoxy-6H-benzo(g)-1,3-benzodioxolo(5,6-a)quinolizine
(+-)-Tetrahydroberberine
5,8,13,13a-Tetrahydro-9,10-dimethoxy-6H-benzo[g]-1,3-benzodioxolo[5,6-a]quinolizine
16,17-dimethoxy-5,7-dioxa-13-azapentacyclo(11.8.0.02,10.04,8.015,20)henicosa-2,4(8),9,15(20),16,18-hexaene
RefChem:573702
208-338-2
Tetrahydroberberine
dl-Canadine
29074-38-2
Berberine, tetrahydro-
NSC 94918
(d,l)-Tetrahydroberberine
6H-Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizine,5,8,13,13a-tetrahydro-9,10-dimethoxy-
CHEMBL275097
Berbine, 9,10-dimethoxy-2,3-(methylenedioxy)-
NSC 36351
Canadine dl-form
NSC36351
5,8,13,13a-Tetrahydro-9,10-dimethoxy-6H-benzo(g)benzo-1,3-dioxolo(5,6-a)quinolizine
6H-Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizine, 5,8,13,13a-tetrahydro-9,10-dimethoxy-
9,10-Dimethoxy-5,8,13,13a-tetrahydro-6H-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinoline
6H-Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizine, 5,8,13,13a-tetrahydro-9,10-dimethoxy-
16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0(2),(1)?.0?,?.0(1)?,(2)?]henicosa-2,4(8),9,15(20),16,18-hexaene
EINECS 208-338-2
UNII-V2SSH085X8
NCGC00016486-01
CAS-522-97-4
Prestwick_186
(+-)-Canadine
(+/-)-Canadine
(.+-.)-Canadine
Tetrahydroberberine,THB
CANADINE [MI]
(+-)-Tetrahydroberberin
(.+/-.)-Canadine
Prestwick0_000672
Prestwick1_000672
Prestwick2_000672
Prestwick3_000672
CANADINE (DL-)
Canadine, (.+-.)-
TimTec1_005946
Oprea1_387569
Oprea1_388593
(.+-.)-Tetrahydroberberine
BSPBio_000763
MLS001202314
SCHEMBL232164
Tetrahydroberberine (Standard)
SPBio_002684
CANADINE DL-FORM [MI]
BPBio1_000841
orb1304904
SCHEMBL2786492
CANADINE, (+/-)-
HY-N0925R
HMS1550O06
HMS1570G05
HMS2097G05
HMS2852B23
HMS3358B11
HMS3886O13
HMS5116I10
CAA08696
EBA07438
FAA09657
HY-N0925
NSC94918
Tox21_110451
BBL028121
BDBM50203122
MFCD00067284
s5153
STK722197
AKOS000277103
AKOS021856290
Tox21_110451_1
CCG-202815
FC19659
NCGC00173359-04
NCGC00173359-06
NCGC00173359-08
AC-34748
DA-58438
NCI60_003328
NCI60_042115
SMR000393885
ST047929
VS-08674
Berbine,10-dimethoxy-2,3-(methylenedioxy)-
NS00080322
522C974
AC-542/20643025
AE-508/21132023
BRD-A69950438-001-04-5
BRD-A69950438-001-11-0
Q27109653
Berbine,10-dimethoxy-2,3-(methylenedioxy)-, (.+-.)-
6H-Benzo[g]-1,6-a]quinolizine, 5,8,13,13a-tetrahydro-9,10-dimethoxy-
5,8,13,13?-Tetrahydro-9,10-dimethoxy-6H-benzo[g]-1,3-benzodioxolo[5,6-?]quinolizine
6H-Benzo[g]-1,6-a]quinolizine, 5,8,13,13a-tetrahydro-9,10,dimethoxy-, (.+-.)-
(1S)-16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0^{2,10.0^{4,8.0^{15,20]henicosa-2,4(8),9,15(20),16,18-hexaene
10-METHOXY-5,8,13,13A-TETRAHYDRO-6H-[1,3]DIOXOLO[4,5-G]ISOQUINO[3,2-A]ISOQUINOLIN-9-YL METHYL ETHER
16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0^{2,10.0^{4,8.0^{15,20]henicosa-2,4(8),9,15(20),16,18-hexaene
9,10-bis(methyloxy)-5,8,13,13a-tetrahydro-6H-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinoline
9,10-dimethoxy-5,6,7,8,13,13a-hexahydro-2H-1,3-dioxoleno[4,5-g]isoquinolino[3, 2-a]isoquinoline
9,10-Dimethoxy-5,8,13,13a-tetrahydro-6H-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinoline #
Isoquinolino[2,1-b]isoquinoline, 5,6,7,8,13,13a-hexahydro-2,3-methylenedioxy-9,10-dimethoxy-
Solubility of 16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaene
The solubility of *16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaene* can be quite complex to characterize due to its intricate molecular structure and the presence of various functional groups.
Generally, the solubility behavior of such a compound can be influenced by several factors:
As stated, the exact solubility can vary widely and may be further examined through experimental methods or predictive modeling. It is important to consider that "solubility" is not just a binary state; rather, it can be influenced by conditions such as:
In conclusion, understanding the solubility of *16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaene* is essential for its practical applications, and further study is warranted to fully assess its solubility characteristics under various conditions.